The Magazine for Sleep Professionals
Wednesday, September 23, 2026
Fans of the popular YouTube channel SleepTech Talk can now purchase the podcast’s new book: SleepTech Talk: Conversations That Are Changing Sleep Medicine (First Edition, August 2026) on Amazon. SleepTech Talk captures the dramatic evolution of sleep health, offering a comprehensive synthesis drawn from over 120 podcast episodes, 8 million […]
Patients diagnosed with a temporomandibular disorder (TMD) are at increased risk for obstructive sleep apnea (OSA) compared to people without the disorder, according to a study published in the Journal of Oral and Maxillofacial Surgery (JOMS), the peer-reviewed official journal of the American Association of Oral and Maxillofacial Surgeons (AAOMS). TMD […]
New Current Procedural Terminology codes for unattended sleep testing have been included by the Centers for Medicare and Medicaid Services in the Medicare physician fee schedule proposed rule. The updated CPT code set, which the American Academy of Sleep Medicine helped develop and advance, is intended to better align coding […]
The American Academy of Dental Sleep Medicine (AADSM) announced that 2,500 dentists across the country have achieved AADSM Qualified Dentist status, strengthening patient access to oral appliance therapy (OAT) for obstructive sleep apnea (OSA). OAT offers a comfortable, clinically-proven treatment option for snoring and OSA. The therapy uses a custom-fit oral […]
HoneyNaps, specializing in AI-powered sleep medical devices, has developed a next-generation wireless polysomnography system that combines patch-based skin sensors with artificial intelligence-driven analysis. Polysomnography (PSG) is the standard diagnostic test for sleep disorders such as sleep apnea. Conventional PSG, however, generally requires patients to spend a night at a hospital […]
Home sleep testing has come a long way over the past decade. The industry has moved beyond simply asking whether a patient can be tested at home. Today, the conversation centers around how effectively, accurately, comfortably, and efficiently that testing can be performed. After more than 16 years in the […]
Nyxoah SA announced that the first patient has been implanted in BREATHE, the Company’s U.S. post-approval study of the Genio® system. The procedure was performed by Rolando Molina, MD, otolaryngologist at South Florida ENT Associates. Edward Mezerhane, MD, FAASM, FACP, DABOM, CPI, sleep medicine physician at PharmaDev Clinical Research Institute […]
“Sleep-maxxing” is framed as a commitment to wellness, however clinical evidence suggests this hyper-fixation often functions as a catalyst for sleep impairment. The 2026 American Journal of Lifestyle Medicine review emphasizes that sleep is a process best supported by circadian rhythm alignment and low physiological arousal. When individuals impose rigid […]
Alkermes plc announced the publication of data from the Vibrance‑1 phase 2 study of alixorexton in adults with narcolepsy type 1 (NT1) in The Lancet Neurology. Alixorexton is a novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development for the treatment of NT1, narcolepsy type 2 (NT2) and […]
ProSomnus Sleep Technologies (“ProSomnus”) has announced a significant victory in its intellectual property enforcement action, reinforcing the Company’s commitment to protecting the innovations, technologies, and proprietary assets that support advances in sleep medicine. The United States District Court for the Southern District of Florida adopted in full the Magistrate Judge’s Report […]
